CANDEL THERAPEUTICS INC (CADL) Stock Analyst Ratings
NASDAQ:CADL - Nasdaq - US1374041093 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to CADL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.42. This target is 255.81% above the current price.
CADL was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CADL.
In the previous month the buy percentage consensus was at a similar level.
CADL was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-20 | Citigroup | Initiate | Buy |
| 2025-02-19 | Canaccord Genuity | Initiate | Buy |
| 2025-02-07 | B of A Securities | Initiate | Buy |
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-03-31 | Credit Suisse | Maintains | Outperform |
| 2022-12-07 | Credit Suisse | Maintains | Outperform |
| 2022-12-02 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-19 | BMO Capital | Initiate | Outperform |
| 2021-08-23 | UBS | Initiate | Buy |
| 2021-08-23 | Credit Suisse | Initiate | Outperform |
| 2021-08-23 | Jefferies | Initiate | Buy |